AML3D said US Navy contracts beefed up its results for the 2026 financial year that was defined by record revenue, a first profitable half-year and continued successful execution of the company’s “US Scale Up” strategy.
AML3D’s revenue of $12.5 million increased 70% on the prior corresponding period (“PCP”). The company’s order book peaked at $29 million during the year, comprising $20 million of new orders and $9 million of orders carried forward from the prior year. For the second half of FY26, from 1 January to 30 June 2026, AML3D recorded its first half-year EBITDA profit of $608,000. This move into profit demonstrates progress against AML3D’s growth strategy and supports the company’s focus on growing shareholder value.
FY26 performance was driven by surging demand for AML3D’s proprietary ARCEMY metal 3D printing technology within the US Defence sector, particularly the US Navy’s Maritime Industrial Base (“MIB”). From a standing start in 2023, AML3D has signed contracts to deploy 14 ARCEMY systems into the US Navy’s supply chain, together with two further orders for systems supporting high-value US industrial manufacturing. In addition, during FY26 AML3D signed another, $2.6 million, contract to supply high demand, non-safety critical replacement components used in US Navy submarines, This demand means AML3D enters FY27 with $16.8 million of contracted work secured and a global sales pipeline estimated at $78 million at 30 June 2026.
AML3D is continuing to embed its ARCEMY technology within the US Navy MIB supply chain while diversifying into new high-value sectors and globally significant defence markets. This broadens the company’s addressable market and supports future revenue opportunities.
During FY26, following a competitive tender process, AML3D deployed its first ARCEMY system to the US utility sector to support the Tennessee Valley Authority’s (“TVA”) power generation repair fleet. TVA is federally owned and is the sixth-largest power supplier and largest public utility in the USA. AML3D also deployed its first ARCEMY system to US industrial manufacturer FasTech, which manufactures and supplies parts for Defence, Aerospace, Energy and other high-demand sectors.
AML3D has also entered the globally significant UK defence market. In FY26, AML3D progressed its material feasibility program for BAE Systems in the UK and agreed UK and European distribution deals. Entry into the UK defence market means AML3D now has defence relationships in Australia, the UK and the USA, the three partners in the trilateral AUKUS defence pact. The Company is working with all three partners to secure additional contracts to support AUKUS.
AML3D enters the 2027 financial year (“FY27”) in a position of strength. The company has $16.8 million of orders in hand, an estimated $78 million sales pipeline and continues to see strong and increasing demand for its advanced manufacturing technology.
AML3D’s strong balance sheet, with a $26.8 million cash balance at 30 June 2026, provides the financial capacity to continue its planned $12 million investment to double US capacity and keep pace with US Defence and industrial manufacturing demand in FY27. AML3D also has the cash reserves to fund a $5 million investment in a UK Technology Centre to support UK and European demand. In Australia, the Company will finalise the $2.24 million program developing next-generation advanced manufacturing technology, has completed an installed manufacturing base to support AUKUS demand and has been onboarded to the AUKUS Vendor Qualification (DIVQ) Program.
AML3D’s order book, sales pipeline, cash position and increasing global manufacturing capacity position the Company to target continued financial and operational growth across Australia, the US and the UK in FY27. Continued execution of this strategy is expected to support increased shareholder value over time.
Commenting on the results, AML3D Managing Director Sean Ebert said, “The 2026 financial year saw rapid growth in ARCEMY® system installations and component manufacturing in the USA. It is encouraging to see our strategy of moving beyond the US Defence market begin to gain traction. During the year, we achieved record revenue growth and delivered our first profitable half-year in the second six months. Demand that supported our FY26 performance has continued into FY27. While we continue to deliver the $16.8 million orders in hand, we are also working to convert our $78 million global sales pipeline and have visibility on potential near-term contracts in the US and the UK. Our strong balance sheet means we have the capacity to complete our planned $17 million investment to double US manufacturing capacity and establish a European Technology Centre to support growth. We are focused on continuing AML3D’s multi-year track record of record delivery and building shareholder value over time.”











